(Keynote Presentation) Cannabis legalization is a success story with a uniquely Canadian story and one that fits with our national spirit as risk takers and innovators. As we fast approach recreational legalization, it's an opportunity to take stock of where we are, where we've come from, and what is ahead. This presentation will speak to the current cannabis industry with a focus on the global potential of medical cannabis as well as the incredible disruptive potential that cannabis presents now and into the future. SPONSORED BY:
(Keynote Presentation) -Future outlook of cannabis legalization on the international stage -Canada’s role on the international level -Aurora’s current & future operations/role in Europe -Aurora’s current strategic objectives in Europe -Building an international, full integrated cannabis company
(Panel Discussion) We’re looking forward to life after legalization. But it behooves us to look back as well. Hundreds of thousands of Canadians were charged with cannabis offences in this decade alone – the majority of them for simple possession. Could their records be cleared? Is anyone liable for a cannabis smoker’s lost job opportunities and other criminal record ramifications? Will there at least be an apology? Going forward, how will a new openness affect marijuana’s integration into everyday life? Will “stoner stigmas” disappear? Our experts pull out their crystal ball and read the weed.
(Panel Discussion) On January 17, 2018, Canopy Growth Corporation announced that BMO Capital Markets and GMP Securities are leading its $175 million bought deal offering of roughly five million shares. The Bank of Montreal's participation in a major financing deal with a licensed marijuana producer marks a massive policy shift for Canada's biggest banks, which may be warming up to the cannabis sector. Until recently, Canadian banks have been reluctant to service the country's cannabis industry, leaving smaller banks and financial institutions to cash in on cannabis companies' financing and commercial banking needs. Join our expert panellists who will discuss: · barriers that have prevented big banks from financing cannabis companies in the past; · [...]
(Panel Discussion) This session will explore the good, bad, and ugly of the federal Cannabis Act and what consumers need to know to stay on-side of the law as the country moves to legalize cannabis. Alongside permitting the purchase and cultivation of cannabis under certain conditions, the government will also introduce approximately 45 new criminal offences that Canadians may be charged with. The panel will explore some of the differences in provincial regulations, such as restrictions on consumption, transportation, and cultivation, and will end the session by fielding questions from the audience.
(Panel Discussion) With J-day fast approaching, Ottawa is grappling with how to enforce laws against driving while high. The health ministry has announced police will administer roadside saliva tests for drugs and is spending $161 million to train officers. But police and the courts are having trouble even making drunk-driving stick these days, with court decisions against 90-day Immediate Roadside Prohibitions, for example. And with a recreational drug of uncertain duration and effect, the legal quagmire could get way stickier. This panel of legal and social experts weigh the challenges facing police, the civic responsibility of users and the straight dope on how pot affects driving.
(Panel Discussion) 'The Worlds 1st International Cannabis in the Work Place’ platform across multidisciplines and expertise’: Combining Business, HR, Legal and a Medical approach to evidenced based solutions.
(Keynote Presentation) When your infant is diagnosed with cancer life as you know it ends, and a new one takes shape. One of uncertainty, filled with fear, and hopes for one day finding a cure. But when there is no cure, what do you do? Tracy Ryan’s journey has taken her from diagnosis of her baby to pre-clinical pediatric cancer trials with some of the top researchers in the world. Learn about her path, how her daughter’s brain tumor is now growing in humanized mice that pump human blood, and how she plans to turn the medical industry on its’ head.